BioLife Solutions, Inc. (BLFS)

BioLife Solutions Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	100.14	82.25	75.86	76.24	119.16	48.09
Revenue Growth (YoY)	87.53%	8.44%	-0.50%	-36.02%	147.79%	75.69%
Cost of Revenue	35.77	28.58	29.92	29.33	80.98	20.24
Gross Profit	64.37	53.67	45.93	46.91	38.18	27.85
Selling, General & Admin	56.57	50.15	55.97	44.93	47.67	21.69
Research & Development	9.55	7.91	12.07	8.67	11.82	6.72
Amortization of Goodwill & Intangibles	2.79	2.74	3.52	3.99	8.2	3.03
Operating Expenses	68.91	60.8	71.57	57.59	67.7	31.44
Operating Income	-4.54	-7.13	-25.63	-10.68	-29.52	-3.59
Interest Expense	-0.02	-0.72	-1.45	-0.28	-0.49	-
Interest & Investment Income	1.87	-	-	-	-	0.04
Other Non Operating Income (Expenses)	0.63	0.5	1.3	0.66	0.17	3.6
EBT Excluding Unusual Items	-2.06	-7.35	-25.78	-10.3	-29.84	0.05
Merger & Restructuring Charges	-	-	-	-	-2.77	-1.08
Gain (Loss) on Sale of Investments	-	-4.07	-	0.7	-	1.32
Other Unusual Items	-	-	7.31	4.75	3.58	-1.58
Pretax Income	-17.58	-11.43	-18.47	-4.85	-29.03	-1.28
Income Tax Expense	0.25	-0.04	-0.02	-5.24	-20.12	-3.26
Earnings From Continuing Operations	-17.82	-11.39	-18.45	0.39	-8.91	1.98
Earnings From Discontinued Operations	14.62	-8.8	-49.56	-140.19	-	-
Net Income to Company	-3.21	-20.18	-68	-139.81	-8.91	1.98
Net Income	-3.21	-20.18	-68	-139.81	-8.91	1.98
Preferred Dividends & Other Adjustments	-	-	-	-	-	0.16
Net Income to Common	-3.21	-20.18	-68	-139.81	-8.91	1.82
Shares Outstanding (Basic)	47	46	44	42	39	27
Shares Outstanding (Diluted)	47	46	44	43	39	27
Shares Change (YoY)	3.88%	5.37%	1.50%	11.87%	41.01%	40.32%
EPS (Basic)	-0.07	-0.44	-1.56	-3.29	-0.23	0.07
EPS (Diluted)	-0.07	-0.44	-1.56	-3.29	-0.23	-0.06
Free Cash Flow	10.04	3.14	-23.74	-22.41	-19.35	-1.16
Free Cash Flow Per Share	0.21	0.07	-0.54	-0.52	-0.50	-0.04
Gross Margin	64.28%	65.25%	60.55%	61.53%	32.04%	57.92%
Operating Margin	-4.53%	-8.67%	-33.79%	-14.01%	-24.77%	-7.46%
Profit Margin	-3.20%	-24.54%	-89.65%	-183.38%	-7.48%	3.79%
Free Cash Flow Margin	10.02%	3.81%	-31.29%	-29.39%	-16.24%	-2.42%
EBITDA	-1.9	-1.64	-18.5	-3.1	-16.65	1.48
EBITDA Margin	-1.90%	-1.99%	-24.39%	-4.06%	-13.98%	3.08%
D&A For EBITDA	2.64	5.49	7.13	7.58	12.87	5.07
EBIT	-4.54	-7.13	-25.63	-10.68	-29.52	-3.59
EBIT Margin	-4.53%	-8.67%	-33.79%	-14.01%	-24.77%	-7.46%
Revenue as Reported	100.14	82.25	75.86	76.24	119.16	48.09
Advertising Expenses	-	0.9	0.8	0.4	0.6	0.17

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q